Treatment-related adverse events of antibody-drug conjugates in clinical trials: A systematic review and meta-analysis. [PDF]
Antibody–drug conjugates (ADCs) have complex molecular structures and have been tested in numerous clinical trials. Therefore, understanding the mechanisms of their toxicity when applied in medical practice is of high importance.
Li J +14 more
europepmc +7 more sources
Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis [PDF]
AimThis study comprehensively assesses the incidence and profiles of treatment-related adverse events (trAEs) of immune checkpoint inhibitor (ICI)-based therapies across cancer at various sites.MethodsWe systematically searched the PubMed, Embase, and ...
Xin Shen +6 more
doaj +3 more sources
Key Points Question Is there any difference in treatment-related adverse events and outcomes between patients with early-onset (age
Meng L +11 more
europepmc +4 more sources
Treatment-related adverse events and response rate to immune checkpoint inhibition [PDF]
Background Immune checkpoint inhibition (ICI) represents a novel treatment modality for refractory cancers, and improving prediction of potential responders is critical. Method We hypothesized that ICI is a systemic-effecting mechanism.
Yanmin Li +4 more
doaj +5 more sources
Treatment strategies and treatment-related adverse events in MG according to the age of onset [PDF]
IntroductionEarly-onset (EOMG) and late-onset (LOMG) are distinct groups of MG patients. It is unclear if treatment strategies and treatment-related adverse events may differ according to the age of MG onset.MethodsThis single-center retrospective study ...
João Moura +13 more
doaj +4 more sources
Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis. [PDF]
Summary Background Given the increasing use of HER2-targeted antibody–drug conjugates (ADCs) worldwide, the summary of toxicity incidence and profiles of these drugs is crucial to provide reference for clinical application.
Fu Z, Liu J, Li S, Shi C, Zhang Y.
europepmc +2 more sources
Treatment-related adverse events of chimeric antigen receptor-T therapies for cancers in clinical trials: a systematic review and meta-analysis. [PDF]
Summary Background Chimeric antigen receptor (CAR)-T cell therapies are being tested in many ongoing trials against hematologic malignancies and solid tumors.
Zhu Y, Liu K, Rosen ST, Liu W, Zhu H.
europepmc +2 more sources
Objective: The aim of our study is to evaluate treatment related adverse events in children with attention-deficit/ hyperactivity disorder (ADHD) using atomoxetine.
Nurdan Kasar +2 more
doaj +3 more sources
Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review [PDF]
BackgroundImmune Checkpoint Inhibitors (ICI) have been progressively used in cancer treatment and produced unique toxicity profiles. This systematic review aims to comprehend the patterns and occurrence of treatment-related adverse events (trAEs) based ...
Tao Ouyang +19 more
doaj +3 more sources
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis. [PDF]
While the occurrence of immune‐related adverse events has been recognized as a prognostic marker in patients receiving immune checkpoint inhibitors, the prognostic significance of treatment‐related adverse events (trAEs) in patients undergoing antibody ...
Taguchi S +37 more
europepmc +2 more sources

